Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment

NCT00980330

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • Jacksonville, Florida, United States
  • Miami, Florida, United States
View all 78 locations
View Trial Details
Completed

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

NCT00530920

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.107.49002 Boehringer Ingelheim Investigational Site Berlin, Germany
  • 1182.107.49004 Boehringer Ingelheim Investigational Site Berlin, Germany
  • 1182.107.49003 Boehringer Ingelheim Investigational Site Frankfurt am Main, Germany
  • 1182.107.49001 Boehringer Ingelheim Investigational Site München, Germany
View Trial Details
Completed

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa

NCT02028676

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • MRC /UVRI Uganda Research Unit on AIDS Entebbe, Uganda
  • Joint Clinical Research Centre Kampala, Uganda
  • Baylor College of Medicine Children's Foundation Mulago, Uganda
  • University of Zimbabwe Medical School Harare, Zimbabwe
View Trial Details
Completed

Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR

NCT00532701

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • National Taiwan University Hospital, Yun-Lin Branch Douliu, Taiwan
  • Kaohsiung Medical University Kaohsiung City, Taiwan
  • Kaohsiung Municipal Hsiao-Kang Hospital Kaohsiung City, Taiwan
  • Paochien Hospital Pingtung City, Taiwan
View Trial Details
Completed

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

NCT01241760

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • La Jolla, California, United States
  • Los Angeles, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
View all 99 locations
View Trial Details
Completed

Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

NCT00869557

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Health for Life Clinic, PLLC Little Rock, Arkansas, United States
  • The Living Hope Foundation Long Beach, California, United States
  • Peter J. Ruane, MD, Inc. Los Angeles, California, United States
  • Orange Coast Medical Group Newport Beach, California, United States
View all 30 locations
View Trial Details

Related conditions